Cancer treatment in Tijuana, Mexico using stem cells can mean very different things, and that distinction matters before you pay or travel. Immunity Therapy Center currently describes a separate one-day umbilical-cord stem-cell program priced at $4,995 and a three-week outpatient cancer program priced at $18,995. Those provider-stated prices do not establish that an intravenous stem-cell infusion treats cancer. Before considering stem cell cancer treatment in Tijuana, Mexico at Immunity Therapy Center, confirm exactly what is proposed, whether standard oncology care will continue, and which current COFEPRIS sanitary authorization applies to any cell handling or regenerative-medicine activity.
Quick Summary: Stem Cell Cancer Treatment in Tijuana at ITC
- Provider-stated cost: ITC publicly lists $18,995 for a three-week outpatient cancer program, $29,995 for an inpatient program, and $4,995 for a separate one-day umbilical-cord stem-cell program. Ask for a written, itemized quote because inclusions can differ.
- Evidence: Hematopoietic stem cell transplantation is an established part of treatment for selected blood cancers. A general intravenous umbilical-cord stem-cell infusion is not the same procedure and should not be assumed to have proven anticancer benefit.
- Safety: Cell-based products can carry risks including infection, immune reactions, contamination, and other serious adverse events. Delaying an evidence-based cancer treatment can create an additional risk.
- Who may consider a consultation: A medically stable patient seeking a second opinion or adjunctive-care discussion after reviewing standard treatment options with an oncology specialist. True stem-cell transplant candidates need a transplant-center evaluation.
- Licensing check: Ask for the facility's exact COFEPRIS sanitary license number and verify that it covers the services being offered, particularly regenerative medicine, stem-cell processing, banking, or transplantation when relevant.
- Recovery: There is no single recovery period. A three-week ITC program describes time receiving care, not a guaranteed recovery timeline. Recovery after an evidence-based hematopoietic stem cell transplant can take months.
- Travel caution: Patients receiving cancer treatment can be immunocompromised. Travel fitness, infection risk, emergency planning, medication supply, insurance, and the current security advisory for Baja California should be reviewed before departure.
What Stem Cell Cancer Treatment in Tijuana, Mexico Actually Means
The phrase “stem cell cancer treatment” is often used for procedures that are medically very different. In conventional oncology, hematopoietic stem cell transplantation replaces blood-forming stem cells after high-dose chemotherapy or radiation. It is used most often for selected leukemias, lymphomas, multiple myeloma, myelodysplastic syndromes, and some other carefully selected conditions.
That is not the same as receiving an intravenous infusion of umbilical-cord-derived cells as a regenerative or immune-support treatment. For most solid tumors, an IV stem-cell infusion should not be described as an established substitute for surgery, chemotherapy, radiotherapy, targeted therapy, hormone therapy, or evidence-based immunotherapy. The exact cell type, intended purpose, processing method, regulatory status, and clinical evidence all matter.
| Term | What it generally means | Cancer evidence | Question to ask |
|---|---|---|---|
| Hematopoietic stem cell transplant | Replacement of blood-forming stem cells, usually after intensive cancer therapy. | Established for selected blood cancers and some related disorders. | Is this being performed by a transplant program with appropriate cell-handling and transplant authorization? |
| Umbilical-cord stem-cell infusion | A cell-based infusion that may be marketed for regenerative or immune purposes. | Not automatically an established anticancer treatment; evidence depends on the product and indication. | What cell type, dose, source, regulatory authorization, trial evidence, and cancer-specific endpoint support its use? |
| Cancer immunotherapy | Treatments that help the immune system recognize or attack cancer, such as checkpoint inhibitors or certain cellular therapies. | Some therapies are standard for specific cancers and biomarkers; others remain investigational. | Is the treatment an approved or guideline-supported therapy for my exact cancer type, stage, and biomarker profile? |
What Immunity Therapy Center in Tijuana Publicly Offers for Cancer Care
Immunity Therapy Center describes its cancer program as a multi-therapy, outpatient or inpatient approach that combines several complementary and alternative modalities. Its public materials also describe a separate one-day umbilical-cord stem-cell program. Because these are provider descriptions, they should be treated as information about what the center says it offers, not as independent evidence of cancer effectiveness.
Patients can review the Immunity Therapy Center cancer-treatment profile and the separate ITC regenerative-medicine profile to organize questions. Clinic profiles should not replace independent verification of licensing, physician credentials, clinical evidence, or oncology recommendations.
Three-Week ITC Cancer Program
Provider materials describe a three-week treatment period and list a current outpatient price of $18,995. A separate inpatient option is listed at $29,995. Exact therapies can vary by patient and should be confirmed in writing before payment.
One-Day ITC Stem-Cell Program
Provider materials list $4,995 for a one-day IV umbilical-cord stem-cell program. The public description says it includes laboratory work and several adjunctive therapies. Patients should ask whether this is proposed for cancer, supportive care, or another indication.
Evidence, Candidate Selection, and Cancer Safety in Tijuana
A patient is not a suitable candidate for a cell-based cancer treatment simply because they have cancer or have exhausted one therapy. Candidacy depends on the exact diagnosis, cancer stage, prior treatments, organ function, blood counts, infection risk, biomarkers, treatment goals, and whether the proposed cell therapy is standard, investigational, complementary, or alternative.
For blood cancers, a hematologist or transplant specialist may recommend autologous or allogeneic hematopoietic stem cell transplantation when established criteria are met. For many solid tumors, stem-cell transplant is not a routine treatment. A regenerative stem-cell infusion should therefore be evaluated separately from a medically indicated transplant.
| Patient situation | What should happen before travel | Why it matters |
|---|---|---|
| Newly diagnosed or potentially curable cancer | Obtain a standard oncology treatment plan and ask how any Tijuana therapy would fit around it. | Replacing time-sensitive evidence-based therapy can reduce treatment opportunities. |
| Relapsed or refractory blood cancer | Ask a hematologist whether transplant, CAR-T therapy, clinical trials, or other established options are appropriate. | True transplant candidacy requires specialized assessment and is different from a regenerative infusion. |
| Advanced solid tumor | Review standard systemic therapy, biomarker-driven options, clinical trials, symptom control, and goals of care. | A general stem-cell infusion is not an established substitute for tumor-specific oncology treatment. |
| Severe infection, unstable symptoms, low blood counts, or poor functional status | Get medical clearance before international travel and verify emergency-capable care at the destination. | Travel and treatment may add infection, bleeding, clotting, or cardiopulmonary risk. |
ITC Cancer Treatment Costs in Tijuana and Financial Comparison
There is no single market price for cancer treatment because the diagnosis, stage, tests, drugs, procedures, complications, and treatment duration differ widely. ITC's public prices are useful for budgeting only when you separate the three-week cancer program from the one-day stem-cell service and confirm exactly what the written quote includes.
| Care option | Current provider-stated price | What to clarify | How to compare |
|---|---|---|---|
| ITC three-week outpatient cancer program | $18,995 | Exact therapies, diagnostics, physician visits, meals, transport, medications, supplements, procedures, and what is excluded. | Compare the written treatment components, not just the package total. |
| ITC three-week inpatient cancer program | $29,995 | Room, nursing, monitoring, emergency escalation, companion arrangements, and services outside the package. | Confirm what makes inpatient care medically necessary and what hospital-level capabilities are available. |
| ITC one-day umbilical-cord stem-cell program | $4,995 | Cell source, cell characterization, testing, regulatory authorization, indication, targeted applications, follow-up, and whether it is included in cancer care. | Do not compare it directly with hematopoietic stem cell transplantation; they are different procedures. |
| Standard oncology care in the United States or Canada | No single comparable package price | Insurance coverage, deductibles, drug regimen, facility fees, surgery, radiation, imaging, and supportive care. | Compare diagnosis-specific care and clinical outcomes, not a bundled Tijuana program against an unrelated home-country bill. |
For broader marketplace context, patients can review cancer treatment pricing in Mexico. Marketplace prices are not a clinical benchmark and should not be used to infer treatment effectiveness or suitability.
Cost methodology: ITC figures above are provider-stated public prices reviewed in August 2026. Prices can change and may not represent the final patient-specific quote.
COFEPRIS Rules for Stem Cells and Regenerative Medicine in Mexico
Mexico regulates health establishments through the Federal Commission for the Protection against Sanitary Risk, known as COFEPRIS. Current COFEPRIS materials state that facilities conducting certain activities involving organs, tissues, cells, stem cells, transplantation, cell banking, or regenerative medicine require the corresponding sanitary authorization before operating.
For regenerative medicine, COFEPRIS's 2026 licensing information specifically lists the COFEPRIS-09-027 sanitary-license procedure for establishments that obtain, process, preserve, or apply progenitor or stem cells, tissues, or cells for regenerative medicine. Other license modalities apply to transplant services, collection centers, banks, and cell handling.
| Verification item | What to request | Why it matters |
|---|---|---|
| Facility sanitary license | Exact current COFEPRIS license number, legal facility name, address, authorized activities, and expiration or status information. | A general business registration does not establish authorization for regenerative-medicine or cell-handling activities. |
| Cell source | Supplier or bank identity, source documentation, chain of custody, donor screening, sterility testing, and release criteria. | Cell products can be contaminated, mislabeled, or handled outside appropriate controls. |
| Clinical indication | Written explanation of whether the proposed use is standard, investigational, complementary, or experimental for your cancer. | Regulatory permission to operate is not the same as proof that a treatment is effective for a specific cancer. |
| Adverse-event plan | Emergency medications and equipment, clinician coverage, hospital transfer pathway, and documentation of adverse events. | Cancer patients can deteriorate quickly from infection, bleeding, thrombosis, allergic reactions, or disease complications. |
How to Choose a Cancer Clinic or Hospital in Tijuana, Mexico
The most important clinic question is not whether the facility looks modern or offers many therapies. It is whether the legal facility is appropriately licensed for the services you will receive, whether complications can be managed promptly, and whether the treatment plan is coordinated with qualified oncology care.
International accreditation can be a useful additional signal when genuinely applicable, but it does not replace Mexican licensing. A facility without international accreditation is not automatically unsafe, and a facility with an international badge is not automatically suitable for your cancer or cell-based treatment.
Clinic checks before stem-cell cancer care
- Current COFEPRIS sanitary license and legal facility name
- Authorization that matches the exact cell or regenerative service
- Written infection-control and adverse-event procedures
- Emergency transfer access to a hospital with appropriate capabilities
- Laboratory, imaging, pathology, and blood-service arrangements
- Structured follow-up after you return home
Documentation to request in writing
- Diagnosis-specific treatment plan and rationale
- Full cell-product description and source
- Expected benefits stated without guarantees
- Known and uncertain risks
- All costs, exclusions, cancellation terms, and extra-treatment charges
- Plan for coordination with your home oncologist
How to Verify Doctors for Cancer Treatment in Tijuana, Mexico
Ask for the full legal name of every physician who will diagnose, prescribe, administer a cell product, or manage cancer complications. In Mexico, a professional cédula is the credential used to document authorization to practice a profession. Patients can verify professional-license information through the national professional registry and should also ask for relevant specialty certification.
If a physician is directing cancer treatment, confirm training and current certification in the specialty that matches the care being delivered, such as medical oncology, hematology, oncologic surgery, radiation oncology, or another relevant field. For stem-cell transplantation, ask specifically about hematology/transplant training and experience rather than assuming general regenerative-medicine experience is equivalent.
| Doctor check | What to verify | Red flag |
|---|---|---|
| Professional license | Name and cédula details in Mexico's professional registry. | The clinic will not provide the physician's full legal name or license details. |
| Cancer specialty | Relevant specialty-board certification and current status where applicable. | A clinician uses a general title but does not document oncology or hematology training relevant to the plan. |
| Experience | Experience with your cancer type, therapy, complications, and the exact cell procedure proposed. | Case volume or experience claims cannot be explained or documented. |
| Care responsibility | Who is physically present, who is on call, and who makes decisions if you become unstable. | The treatment is sold before you know which physician is responsible for your care. |
Patient Demographics and Why International Patients Consider Tijuana for Cancer Care
No independently verifiable 2025–2026 public dataset was found that reports Immunity Therapy Center's patient age, sex, country of origin, cancer type, or travel volume. It would therefore be misleading to create clinic-specific demographic percentages. Patients from the United States and Canada may consider Tijuana because of its proximity to Southern California, private-pay programs, cross-border travel access, and availability of therapies that may be marketed differently from care at home.
The charts below use recent national Mexican mortality data only to show cancer burden by time and age. They do not represent ITC outcomes, treatment effectiveness, clinic patients, or medical-tourism demand.
Mexico Malignant-Tumor Death Rate, Jan–Sep
Source: INEGI, Registered Death Statistics, January–September 2025, published February 25, 2026. *2025 data are preliminary.
Mexico Malignant-Tumor Deaths by Adult Age, Jan–Sep 2025
Source: INEGI, Registered Death Statistics, January–September 2025. These national data are disease-burden context, not ITC patient demographics.
Tijuana Cancer Treatment Travel, Treatment Timeline, and Recovery Planning
International cancer travel requires more preparation than arranging a hotel and treatment appointment. Cancer itself, chemotherapy, radiation, steroids, transplant history, low blood counts, and other therapies can increase infection or medical-complication risk. Your home oncology team should assess whether you are fit to travel and whether any vaccines, medicines, or preventive measures need adjustment.
ITC publicly describes its main cancer program as lasting about three weeks, but that is a treatment schedule rather than a recovery estimate. If you are undergoing a true hematopoietic stem cell transplant, recovery and immune reconstitution can take months and may require intensive monitoring. A one-day regenerative infusion does not have an evidence-based “cancer recovery time” that can be generalized.
| Timeframe | Biological or clinical process | Patient sensation | Activity level | Action required |
|---|---|---|---|---|
| 2–6 weeks before travel | Cancer status and treatment effects may change blood counts, infection risk, and travel fitness. | Varies by disease and prior treatment. | Normal to limited depending on symptoms. | Send records, obtain oncology review, verify licenses and credentials, and establish an emergency plan. |
| Arrival in Tijuana | Clinical reassessment may identify new contraindications or needed tests. | Travel fatigue is common; symptoms should be reported rather than dismissed. | Keep activity moderate until medically assessed. | Confirm final treatment plan before starting any therapy or infusion. |
| During a three-week program | Effects depend entirely on the therapies received and underlying cancer. | Fatigue, appetite changes, pain, or other symptoms may reflect disease, prior therapy, travel, or treatment. | Individualized. | Track symptoms, laboratory results, medication changes, and all procedures for your home team. |
| After returning home | Cancer still requires disease-specific monitoring regardless of how you feel. | Feeling better or worse alone does not show whether a tumor responded. | Follow your oncology team's guidance. | Arrange follow-up imaging, labs, pathology review, and medication reconciliation as clinically indicated. |
Risks, Complications, and Warning Signs After Cell-Based Cancer Treatment
Cell-based products can create risks that differ from conventional cancer drugs. U.S. regulators have reported serious problems associated with unapproved regenerative products, including infections, immune reactions, contamination, neurologic events, and tumor formation. The actual risk for any individual product depends on its source, processing, route, dose, manufacturing controls, and the patient's health.
Cancer patients also face disease-related risks such as infection, anemia, bleeding, blood clots, dehydration, organ dysfunction, pain crises, and treatment interactions. A treatment plan should explain which problems can be managed on site and which require transfer to a hospital.
| Risk or warning sign | Why it matters | Patient action |
|---|---|---|
| Fever, shaking chills, or rapidly worsening weakness | May indicate infection, which can become serious quickly in immunocompromised patients. | Seek urgent medical assessment rather than waiting for a routine clinic visit. |
| Shortness of breath, chest pain, fainting, or new severe swelling | Can signal cardiopulmonary problems, blood clots, infusion reactions, or other emergencies. | Use emergency services or the clinic's documented hospital-transfer pathway. |
| Confusion, seizure, new weakness, or severe headache | May reflect neurologic complications, infection, stroke, metabolic problems, or cancer progression. | Obtain emergency evaluation. |
| Uncontrolled bleeding, black stools, vomiting blood, or rapidly increasing bruising | May reflect low platelets, coagulation problems, treatment effects, or gastrointestinal bleeding. | Seek urgent medical care. |
Questions to Ask Immunity Therapy Center Before Paying for Cancer Treatment
A useful consultation should leave you with enough written information to compare the Tijuana plan with standard oncology care and other options. Ask questions that separate evidence, regulation, clinical responsibility, logistics, and cost rather than focusing only on testimonials or package descriptions.
Treatment and evidence questions
- What is the exact diagnosis, stage, and treatment goal?
- Which therapies are proposed and which are optional?
- What is the evidence for each therapy in my cancer type?
- Is the stem-cell infusion intended to treat cancer, support recovery, or address another condition?
- What objective tests will be used to assess response?
Safety, credentials, and cost questions
- What is the facility's current COFEPRIS license number for the exact services offered?
- Who is the responsible physician and what are their cédula and specialty credentials?
- Where do the cells come from and what release testing is performed?
- Which complications can be managed on site and which require hospital transfer?
- What is the final itemized price, including likely additional charges?
Frequently Asked Questions About Stem Cell Cancer Treatment in Tijuana
Is stem cell therapy a proven cancer treatment in Tijuana, Mexico?
It depends on what “stem cell therapy” means. Hematopoietic stem cell transplantation is established for selected blood cancers. A general IV umbilical-cord or regenerative stem-cell infusion is a different treatment and should not be assumed to have proven anticancer benefit for solid tumors or other cancers.
Does Immunity Therapy Center's $4,995 stem-cell program treat cancer?
ITC publicly describes a $4,995 one-day umbilical-cord stem-cell program, but a provider description is not evidence that the infusion treats cancer. Ask the center to state the intended indication, evidence level, measurable treatment goal, regulatory authorization, and whether your oncologist considers it appropriate.
Which cancers are commonly treated with hematopoietic stem cell transplantation?
Stem cell transplantation is used most often for selected blood cancers and related disorders, including certain leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. Suitability depends on disease features, prior treatment, donor availability when relevant, organ function, age, and overall health.
How much does cancer treatment at Immunity Therapy Center in Tijuana cost?
ITC currently lists $18,995 for a three-week outpatient cancer program and $29,995 for an inpatient program. It separately lists $4,995 for a one-day umbilical-cord stem-cell program. Ask for an itemized patient-specific quote because inclusions, exclusions, extra procedures, and travel expenses can change the total.
Is the stem-cell program included in ITC's three-week cancer package?
Do not assume it is included. ITC publicly presents a separate one-day stem-cell program and a separate three-week cancer program. Ask the clinic for a written treatment schedule and itemized quote showing whether stem cells are proposed for you, what they cost, and why they are being recommended.
How can I verify a Tijuana clinic's COFEPRIS authorization for stem cells?
Ask for the exact sanitary license number, legal facility name, address, and authorized activities. Then compare those details with current COFEPRIS information. For regenerative medicine, COFEPRIS lists a specific sanitary-license procedure, and different authorizations apply to transplantation, collection centers, banks, and other cell-handling activities.
How do I verify a cancer doctor's credentials in Mexico?
Request the physician's full legal name and professional cédula, then verify the credential through Mexico's professional registry. For cancer care, also ask for relevant current specialty certification and experience with your diagnosis. A general medical license alone does not establish expertise in oncology, hematology, or transplantation.
Can I stop chemotherapy or radiation before going to Tijuana?
Do not stop, delay, or alter prescribed cancer treatment without discussing it with the oncology team managing your disease. Timing can be critical. Ask your oncologist to review the Tijuana plan for interactions, treatment delays, infection risks, and whether any proposed therapy would interfere with standard care.
Is immunotherapy the same as stem cell therapy for cancer?
No. Cancer immunotherapy is a broad category of treatments that help the immune system fight cancer, including checkpoint inhibitors and some cellular therapies. Stem cell therapy can refer to blood-forming stem cell transplantation or regenerative cell products. The mechanism, evidence, indication, and regulation differ substantially.
What medical records should I send before a Tijuana cancer consultation?
Provide pathology reports, imaging reports and relevant images, treatment summaries, surgery reports, medication lists, recent laboratory results, molecular or biomarker testing, allergies, major medical conditions, and contact information for your treating oncology team. The clinic may request additional records based on your cancer type and proposed therapy.
How long should I stay in Tijuana for cancer treatment at ITC?
ITC publicly describes many cancer programs as lasting about three weeks, while its separate stem-cell program is described as a one-day service. Your safe travel duration may be longer if you need additional testing, monitoring, complication management, or follow-up before your home oncologist can resume care.
What warning signs need urgent care after a cell-based cancer treatment?
Seek urgent medical assessment for fever with worsening weakness, breathing difficulty, chest pain, fainting, confusion, seizure, new severe neurologic symptoms, uncontrolled bleeding, or rapidly worsening illness. Cancer patients can deteriorate quickly, especially when immunocompromised, so an emergency and hospital-transfer plan should exist before treatment starts.
Compare Cancer Treatment Questions Before You Travel to Tijuana
PlacidWay can help you request written program information, compare treatment costs, and organize questions for providers. Use that information alongside independent COFEPRIS verification and advice from the oncology professionals managing your cancer.
.png)
-(1).png)
.jpg)
.jpg)
Share this listing